Yarbrough Capital’s Boston Scientific BSX Stock Holding History

Yarbrough Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.41M	Hold	38,456	–	–	0.08%	63
2025 Q4	$3.67M	Hold	38,456	–	–	0.11%	62
2025 Q3	$3.75M	Hold	38,456	–	–	0.12%	68
2025 Q2	$4.13M	Hold	38,456	–	–	0.15%	57
2025 Q1	$3.88M	Hold	38,456	–	–	0.17%	57
2024 Q4	$3.43M	Hold	38,456	–	–	0.13%	61
2024 Q3	$3.22M	Hold	38,456	–	–	0.13%	63
2024 Q2	$2.96M	Hold	38,456	–	–	0.12%	61
2024 Q1	$2.63M	Hold	38,456	–	–	0.11%	68
2023 Q4	$2.22M	Hold	38,456	–	–	0.12%	71
2023 Q3	$2.03M	Hold	38,456	–	–	0.12%	73
2023 Q2	$2.08M	Hold	38,456	–	–	0.12%	71
2023 Q1	$1.92M	Hold	38,456	–	–	0.16%	72
2022 Q4	$1.78M	Hold	38,456	–	–	0.14%	67
2022 Q3	$1.49M	Hold	38,456	–	–	0.12%	76
2022 Q2	$1.43M	Hold	38,456	–	–	0.11%	75
2022 Q1	$1.7M	Hold	38,456	–	–	0.1%	81
2021 Q4	$1.63M	Buy	+38,456	New	+$1.62M	0.09%	95

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Yarbrough Capital's BSX Position: Q1 2026 in Review

Yarbrough Capital held its Boston Scientific (BSX) position steady in Q1 2026 at 38,456 shares worth $2.41M. The position accounts for 0.08% of the portfolio, ranked #63.

Yarbrough Capital first reported a position in BSX in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.13M in Q2 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Yarbrough Capital held 38,456 shares of Boston Scientific worth $2.41M as of Q1 2026.
Yarbrough Capital left its Boston Scientific share count unchanged in Q1 2026.
Boston Scientific made up 0.08% of Yarbrough Capital's portfolio in Q1 2026, its #63 holding.
Yarbrough Capital first reported a position in Boston Scientific in Q4 2021 and has held it in 18 quarters since.
Yarbrough Capital's Boston Scientific position peaked at $4.13M in Q2 2025.
1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Yarbrough Capital's 13F filing for Q1 2026, filed 14 Apr 2026.